Daniel Faga

Daniel Faga is currently the President & CEO at AnaptysBio since March 2022. Daniel is also serving as a Board Director at Affini-T Therapeutics since April 2022. Previously, they worked as the Chief Operating Officer at Mirati Therapeutics from January 2020 to November 2021. Before that, they held the position of Chief Business Officer at Spark Therapeutics, Inc. from May 2016 to December 2019. Daniel also worked as a Managing Director at Centerview Partners from 2009 to 2016. Daniel started their career as an Associate at Merrill Lynch from 2007 to 2009, followed by roles as an Associate at PRTM from 2002 to 2005 and at PowerAdvocate from 2001 to 2002.

Daniel Faga pursued their education with a Bachelor of Science degree in Engineering from Cornell University, where they studied from 1997 to 2001. Following this, they furthered their academic journey by completing a Master of Business Administration (MBA) degree at The Wharton School from 2005 to 2007, specializing in Healthcare and Finance.